AI

Artificial intelligence (AI) company Atomwise has signed an exclusive research collaboration with Sanofi to use its AtomNet platform for computational discovery and research of up to five drug targets.  The agreement will see Atomwise receive $20 million from Sanofi to identify, synthesise, and advance lead compounds for up to five targets, which will be exclusive to […]

The next era of laboratory automation is no longer about sample movers or liquid handlers. With big data being the central focus, several new trends have emerged in this space, making laboratory automation better, more powerful, and more accessible. By Anita Ramanathan. Automation goals once revolved around ‘getting more done’. Now, the goal is to […]

Drug discovery company MultiOmic Health and digital health start-up Mesh Bio will work together on an observational clinical study for patients with chronic metabolic disease and increased risk of complications such as chronic kidney disease.   The partnership will provide access to data from patient populations in Asia that have historically been underrepresented in chronic metabolic […]

News round-up by DDW’s Reece Armstrong for 23-27 May   UK investment plans, company appointments to drive strategy, and digital health platforms are some of the themes of this week’s news round-up.    New £20m fund launches to support North West life sciences  A new £20 million fund has been launched in the Northwest of England to […]

R&D cloud platform provider Benchling has launched a new artificial intelligence (AI) programme to help scientists predict 3D structures of novel proteins.    The company has launched a beta version of its AlphaFold programme – an AI platform developed by DeepMind that can predict the 3D structure of a protein from an amino acid sequence. […]

Artificial intelligence company Iktos has announced a collaboration with drug discovery company Sygnature Discovery in a deal designed to accelerate drug discovery and development.  The three-year deal will see Sygnature using Iktos’ de novogenerative design software Makya to facilitate rapid and efficient design of novel compounds and accelerate hit-to-lead/lead optimisation.  Makya is a generative AI-driven de […]

AstraZeneca has identified an additional target for its idiopathic pulmonary fibrosis (IPF) pipeline using an AI system designed by drug discovery company BenevolentAI. It is now the third target from that collaboration that has been identified using BenevolentAI’s platform. AstraZeneca is using the company’s Benevolent Platform across two disease areas – IPF and chronic kidney […]

Exploitation of microbiome science will unlock multiple commercial opportunities across a number of industries including life sciences. But there is a need for more effective data and process management to get the best from microbiome data, according to Dr Sven Sewitz, Director of Biodata Innovation at Eagle Genomics. The microbiome comprises trillions of diverse bacteria […]

Ahead of SLAS Europe May 24-27, 2022, in Dublin, Jill Hronek, SLAS Director, Marketing & Communications, shares how the SLAS community responded to the unprecedented need for laboratory automation internationally, and reflects on the conference theme, ‘Where Imagination Inspires Innovation’. Welcome back to the SLAS Europe Conference and Exhibition; it seems like a very long […]

With Covid-19 taking so much of the drug discovery and development’s focus over the last two years, it has been easy to overlook other areas within the sector that deserve our attention. With Q1 on its way out, Lu Rahman highlights the technology that will play a valuable role for the rest of the year. […]